相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Structural View on Medicinal Chemistry Strategies against Drug Resistance
Stefano Agnello et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Automated De Novo Drug Design: Are We Nearly There Yet?
Gisbert Schneider et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Design and Structural Evolution of Matrix Metalloproteinase Inhibitors
Thomas Fischer et al.
CHEMISTRY-A EUROPEAN JOURNAL (2019)
Drug Design Inspired by Nature: Crystallographic Detection of an Auto-Tailored Protease Inhibitor Template
Flavio M. Gall et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive Inhibitors
Ying Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Binding-Site Compatible Fragment Growing Applied to the Design of beta(2)-Adrenergic Receptor Ligands
Florent Chevillard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
Heba Alshaker et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
In Silico Identification of JMJD3 Demethylase Inhibitors
C. Esposito et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets
Jerry M. Adams et al.
CELL DEATH AND DIFFERENTIATION (2018)
Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
Tairan Liu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor
Nicole Senn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Avi Ashkenazi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase Inhibitor
Thomas Fischer et al.
CHEMISTRYOPEN (2017)
GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future
Mudasir Maqbool et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Lu Zhang et al.
DRUG DISCOVERY TODAY (2017)
A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring
Jonathan Cramer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
6 Deep Learning in Drug Discovery
Erik Gawehn et al.
MOLECULAR INFORMATICS (2016)
Recent advances in the development of sphingosine kinase inhibitors
Melissa R. Pitman et al.
CELLULAR SIGNALLING (2016)
Use of machine learning approaches for novel drug discovery
Angelica Nakagawa Lima et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Application of Fragment-Based de Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 Beta
Hwangseo Park et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
De Novo Design at the Edge of Chaos
Petra Schneider et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies
Thomas Fischer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Optimization of TRPV6 Calcium Channel Inhibitors Using a 3D Ligand-Based Virtual Screening Method
Celine Simonin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
De Novo Fragment Design for Drug Discovery and Chemical Biology
Tiago Rodrigues et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Machine-learning approaches in drug discovery: methods and applications
Antonio Lavecchia
DRUG DISCOVERY TODAY (2015)
Stereoselective virtual screening of the ZINC database using atom pair 3D-fingerprints
Mahendra Awale et al.
JOURNAL OF CHEMINFORMATICS (2015)
Merging Allosteric and Active Site Binding Motifs: De novo Generation of Target Selectivity and Potency via Natural-Product-Derived Fragments
Jan Lanz et al.
CHEMMEDCHEM (2015)
Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain
Paramita Mukherjee et al.
CHEMICAL SOCIETY REVIEWS (2014)
De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-XL: Synthesis, Structural and Biochemical Characterization
Ryan M. Brady et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Future De Novo Drug Design
Gisbert Schneider
MOLECULAR INFORMATICS (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Strategic Targeting of Multiple Water-Mediated Interactions: A Concise and Rational Structure-Based Design Approach to Potent and Selective MMP-13 Inhibitors
Thomas Fischer et al.
CHEMMEDCHEM (2013)
Discovery of a Potent Inhibitor of Replication Protein A Protein- Protein Interactions Using a Fragment-Linking Approach
Andreas O. Frank et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Classification of scaffold-hopping approaches
Hongmao Sun et al.
DRUG DISCOVERY TODAY (2012)
Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer's Disease: Design, Synthesis, and Characterization of Pyrazines
Stefan Berg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Rational Approaches to Improving Selectivity in Drug Design
David J. Huggins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Markus Hartenfeller et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Cancer-Associated Loss-of-Function Mutations Implicate DAPK3 as a Tumor-Suppressing Kinase
John Brognard et al.
CANCER RESEARCH (2011)
Compound Design by Fragment-Linking
Osamu Ichihara et al.
MOLECULAR INFORMATICS (2011)
Enabling future drug discovery by de novo design
Markus Hartenfeller et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2011)
Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization
Sarah R. Langdon et al.
MOLECULAR INFORMATICS (2010)
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Joern R. Steinert et al.
NEUROSCIENTIST (2010)
Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase
Alvin W. Hung et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability
Graham R. Lawton et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Discovery of novel sphingosine kinase 1 inhibitors
Yibin Xiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Structure and Function of Benzoylurea-Derived α-Helix Mimetics Targeting the Bcl-xL/Bak Binding Interface
Johanna M. Rodriguez et al.
CHEMMEDCHEM (2009)
Discovery of Highly Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase by Fragment Hopping
Haitao Ji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The structure of CDK4/cyclin D3 has implications for models of CDK activation
T. Takaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fragment-based de Novo ligand design by multiobjective evolutionary optimization
Fabian Dey et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors
Haitao Ji et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Metalloproteases as potential therapeutic targets in arthritis treatment
Andrew D. Rowan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects
Adam R. Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Scaffold-hopping: How far can you jump?
Gisbert Schneider et al.
QSAR & COMBINATORIAL SCIENCE (2006)
Snapshots of the reaction mechanism of matrix metalloproteinases
Ivano Bertini et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
ZIP kinase, a key regulator of myosin protein phosphatase 1
TAJ Haystead
CELLULAR SIGNALLING (2005)
Computer-based de novo design of drug-like molecules
G Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase
ML Flinspach et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Docking and scoring in virtual screening for drug discovery: Methods and applications
DB Kitchen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Computer modeling of selective regions in the active site of nitric oxide synthases: Implication for the design of isoform-selective inhibitors
HT Ji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
SYNOPSIS: SYNthesize and OPtimize system in silico
HM Vinkers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: Antagonism of the bak BH3/Bcl-xL complex
JT Ernst et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
The novel binding mode of N-Alkyl-N′-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis
HY Li et al.
BIOCHEMISTRY (2002)
Development of a potent Bcl-xL antagonist based on α-helix mimicry
O Kutzki et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Structure-based generation of a new class of potent Cdk4 inhibitors:: New de novo design strategy and library design
T Honma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
A novel approach for the development of selective Cdk4 inhibitors: Library design based on locations of Cdk4 specific amino acid residues
T Honma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein
M Ikuta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks
G Schneider et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2000)
LigBuilder: A multi-purpose program for structure-based drug design
RX Wang et al.
JOURNAL OF MOLECULAR MODELING (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
